Zobrazeno 1 - 3
of 3
pro vyhledávání: '"drug effects [Inflammasomes]"'
Autor:
Eicke Latz, Victor Saavedra, Matthew Mangan, Anke Penno, Mario A. Lauterbach, Lars Kuerschner, Christoph Thiele
Publikováno v:
Autophagy
Autophagy 17(8), 1947-1961 (2021). doi:10.1080/15548627.2020.1804677
Autophagy 17(8), 1947-1961 (2021). doi:10.1080/15548627.2020.1804677
1-Deoxysphingolipids (deoxySLs) are atypical sphingolipids of clinical relevance as they are elevated in plasma of patients suffering from hereditary sensory and autonomic neuropathy (HSAN1) or type 2 diabetes. Their neurotoxicity is described best b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7633b2425588b3dc8eb6ca3aa34a32
https://pubmed.ncbi.nlm.nih.gov/32835606
https://pubmed.ncbi.nlm.nih.gov/32835606
Autor:
Douglas T. Golenbock, Pilar Martinez-Martinez, Hannah Scheiblich, Michael T. Heneka, Eicke Latz, Anna Schlütter
Publikováno v:
Journal of neurochemistry 143(5), 534-550 (2017). doi:10.1111/jnc.14225
Journal of Neurochemistry, 143(5), 534-550. Wiley
Journal of Neurochemistry, 143(5), 534-550. Wiley
Inflammation within the CNS is a major component of many neurodegenerative diseases. A characteristic feature is the generation of microglia-derived factors that play an essential role in the immune response. IL-1 beta is a pro-inflammatory cytokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f4e2df3f81f002082cc63906cb0e02c
https://doi.org/10.1111/jnc.14225
https://doi.org/10.1111/jnc.14225
Autor:
Katherine A. Fitzgerald, Anette Christ, Ellen M. Gravallese, Eicke Latz, Gregory I. Vladimer, Lukas Bossaller, Ann Marshak-Rothstein, Jonathan Kay, Christian Schmidt-Lauber, Hani H. Abujudeh
Publikováno v:
Annals of the rheumatic diseases 74(11), 2062-2069 (2014). doi:10.1136/annrheumdis-2013-204900
Objective Nephrogenic systemic fibrosis (NSF) is a progressive fibrosing disorder that may develop in patients with chronic kidney disease after administration of gadolinium (Gd)-based contrast agents (GBCAs). In the setting of impaired renal clearan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97904bcb727d9ff7af6db6131359aee0
https://doi.org/10.1136/annrheumdis-2013-204900
https://doi.org/10.1136/annrheumdis-2013-204900